DOI:

Update on the EAPCI Women Committee

Update on the EAPCI Women Committee

An interview with Fina Mauri and Maria D. Radu, Chair and Co-Chair

Fina Mauri, MD, PhD

Hospital Universitari Germans Trias i Pujol (Universitat Autònoma de Barcelona) Barcelona, Spain

Maria D. Radu, MD, PhD

Dept of Cardiology, The Heart Center, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark

What are the aims of the EAPCI Women’s Committee?

At present, our aims are to decrease gender disparity at the patient as well as the professional level such that hopefully, in the future, our committee will no longer be needed.

How are you working to attain these goals?

By investigating the extent and causes of cardiovascular issues related to gender, we seek to have an influence at the patient level. While we are not currently involved in public campaigns to increase awareness of women’s poorer cardiovascular outcomes, we believe that the establishment of relevant data will positively influence the debate seen both from the patient and physician perspective. Furthermore, by working alongside our male interventional colleagues, we wish, together with them, to establish similar professional possibilities for both genders. Today we have an amazing network of women and men working on our different missions. We number around 50 members, with 30 in the steering committee. Our committee is composed of several subgroups, each dealing with different topics: scientific; network and web communications; career building; and subgroups working on improving our relationship with other similar networks, namely the EAPCI Women and WIN group, working with our colleagues in the US, and a subgroup dedicated to improving conditions for female patients and professionals in “challenging” countries.

What are the current challenges?

They are numerous: having the possibility of working as interventional cardiologists despite being women of child-bearing age; having more female representation on the councils of scientific societies; having the economic possibility of conducting trials in which the importance of gender differences is examined and detailed in both coronary and structural diseases.

And the future?

Currently, we are conducting a survey on radiation (see the April 2017 electronic issue of EuroIntervention), and a multicentre collaborative study on bioabsorbable vascular scaffolds (BVS) which merges BVS databases with the aim of examining outcomes and gender bias with BVS. In the long term, we hope to have a well-functioning international network which will have come a step closer to the understanding of gender differences in manifestations of cardiac disease and to improving treatment disparities. At the same time, we hope to have gained increased visibility for female interventionalists in both scientific research and daily clinical practice.

What would motivate a young interventionalist to join your committee?

The sense of belonging to an EAPCI committee, and hence being part of the ESC, further reinforces the way we approach our activities, but what really matters is having the possibility of working for something that has a personal meaning – to decrease the disparity between individuals – and to work with passionate professionals who are equally committed, dedicating their time towards a better development of care for all patients – irrespective of whether they are men or women.

http://www.escardio.org/Sub-specialty-communities/European-Association-of-Percutaneous-Cardiovascular-Interventions-%28EAPCI%29/Our-communities/The-EAPCI-Women-Initiative

Join the EAPCI Women Committee for a dedicated meeting at EuroPCR 2017, Wed. afternoon 17 May! Share experiences, enhance visibility and increase the number of members – women and men who are interested in gender-related issues.

To join the EAPCI and the Women Committee write to: [email protected]

NEWS

ESC Congress 2017 Spotlight: “40 years of PCI”. Submit your Late Breaking Science by 21 May 2017!

For more information check out www.escardio.org/ESC2017

EAPCI Fellows Course 2017 will take place at EuroPCR on Monday 15 and Tuesday morning 16 May. For more information, see www.pcronline.com/Courses/EuroPCR/EuroPCR-2017/Programme/EAPCI-Fellows-course

Join us for the free EAPCI webinar on 23 June “Focus on bleeding management strategy in patients under oral anticoagulation after PCI – from randomised clinical trials to the individual patient” with Dr Robert Byrne and Profs Marco Roffi and Andreas Baumbach. Register today!
More information at www.escardio.org/EAPCI - Education section

Volume 12 Number 17
Apr 20, 2017
Volume 12 Number 17
View full issue

Suggested by Cory

Editorial

10.4244/EIJ-D-26-00601 Jun 15, 2026
Unloading the clock: when timing meets physiology in STEMI shock
Møller J and Schrage B
free

Editorial

10.4244/EIJ-D-26-00394 Jun 15, 2026
Transcatheter edge-to-edge repair for primary mitral regurgitation: what lies ahead?
Petronio A and Mazzola M
free

Original Research

10.4244/EIJ-D-25-01308 Jun 15, 2026
Temporal trends in mitral edge-to-edge repair for primary mitral regurgitation
Koell B et al

Flashlight

10.4244/EIJ-D-25-01353 Jun 15, 2026
Transcatheter approximation of papillary muscles
Tekieli L et al
open access

Editorial

10.4244/EIJ-D-26-00479 Jun 1, 2026
Valve thrombosis or valve deterioration: what truly drives the prognosis?
Waksman R and Phichaphop A
free
Trending articles
202.75

State-of-the-Art

10.4244/EIJ-D-21-00089 Jun 11, 2021
Intracoronary optical coherence tomography: state of the art and future directions
Ali ZA et al
free
47.45

NEW INNOVATION

10.4244/EIJ-D-15-00467 Feb 20, 2018
Design and principle of operation of the HeartMate PHP (percutaneous heart pump)
Van Mieghem NM et al
free
42.15

State-of-the-Art

10.4244/EIJ-D-25-00896 Apr 6, 2026
Pretreatment with antiplatelet agents in patients undergoing coronary revascularisation
Kaur G et al
free
35.3

Original Research

10.4244/EIJ-D-25-01006 Mar 16, 2026
Clinical outcomes and haemodynamic response after blinded stress assessment of moderate aortic stenosis
Eerdekens R et al
32.2

State-of-the-Art

10.4244/EIJ-D-25-00874 Jun 1, 2026
TAVI and coronary interventions: indications, technical considerations, and clinical scenarios
Aquino Bruno H et al
free
27.1

Original Research

10.4244/EIJ-D-25-01370 May 21, 2026
Prognostic value of early haemodynamic valve deterioration after TAVI
Trimaille A et al
27.1

Original Research

10.4244/EIJ-D-25-01370 Jun 1, 2026
Prognostic value of early haemodynamic valve deterioration after TAVI
Trimaille A et al
19.5

Original Research

10.4244/EIJ-D-26-00032 May 15, 2026
Glucocorticoids to reduce permanent pacemaker implantation after TAVI: the GLUCO-TAVI randomised trial
Fuertes-Kenneally L et al
X

PCR
Impact factor: 9.5
2024 Journal Citation Reports®
Science Edition (Clarivate Analytics, 2025)
Online ISSN 1969-6213 - Print ISSN 1774-024X
© 2005-2026 Europa Group - All rights reserved